Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.
Mayo Clinic Laboratory and Pathology Research Roundup: May 8 - Insights
This week’s Research Roundup highlights how AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.
Perspectives Archives - Page 7 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Evacuation of a Health Care Facility: When Disaster Strikes - Insights
Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, discusses the evacuation of a health care facility when disaster strikes.
Perspectives Archives - Page 8 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Active Learning: Connecting Teachers and Learners - Insights
Cindy Gosse, Education Specialist in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discusses how to use active learning to better connect teachers and learners.
Staffing to Workload in Phlebotomy Areas: Minimum Staffing Levels - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on minimum-staffing levels, which can override the calculated staffing needs by adding staff to meet potential demands.
Perspectives Archives - Page 6 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
History of Mayo Clinic School of Graduate Medical Education #ThrowbackThursdays - Insights
Ever since Mayo Clinic was established, the institution's goal has been to provide outstanding care to its patients and offer superior education programs that ensure the success of the next generation of medical professionals. Read more...
People Archives - Page 34 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...